Steven Cohen Centessa Pharmaceuticals PLC Transaction History

Point72 Asset Management, L.P.

$39.3 Billion
Q1 2024

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 2,257,718 shares of CNTA stock, worth $20.4 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

2,257,718

Previous 1,840,482 22.67%

Holding current value

$20.4 Million

Previous $14.7 Million 74.14%

% of portfolio

0.06%

Previous 0.04%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$6.73 - $12.2 $2.81 Million - $5.09 Million	417,236 Added 22.67%	2,257,718 $25.5 Million
Q3 2023 Nov 14, 2023	SELL	$6.01 - $8.24 $1.03 Million - $1.41 Million	-170,906 Reduced 8.5%	1,840,482 $11.9 Million
Q2 2023 Aug 14, 2023	BUY	$3.68 - $6.9 $868,134 - $1.63 Million	235,906 Added 13.29%	2,011,388 $12.5 Million
Q1 2023 May 15, 2023	BUY	$3.03 - $4.0 $5.14 Million - $6.78 Million	1,695,782 Added 2127.71%	1,775,482 $6.84 Million
Q4 2022 Feb 14, 2023	SELL	$3.05 - $4.19 $116,205 - $159,639	-38,100 Reduced 32.34%	79,700 $247,000

Q3 2022 Nov 14, 2022	SELL	$3.8 - $5.91 $60,040 - $93,378	-15,800 Reduced 11.83%	117,800 $474,000
Q2 2022 Aug 15, 2022	SELL	$3.18 - $9.85 $2.46 Million - $7.62 Million	-773,400 Reduced 85.27%	133,600 $651,000
Q1 2022 May 16, 2022	SELL	$7.45 - $11.59 $1.42 Million - $2.21 Million	-190,908 Reduced 17.39%	907,000 $8.14 Million
Q4 2021 Feb 14, 2022	BUY	$10.99 - $17.54 $8.74 Million - $14 Million	795,708 Added 263.31%	1,097,908 $12.4 Million
Q3 2021 Nov 15, 2021	BUY	$16.7 - $23.11 $3.38 Million - $4.67 Million	202,200 Added 202.2%	302,200 $5.05 Million
Q2 2021 Aug 16, 2021	BUY	$21.71 - $25.66 $2.17 Million - $2.57 Million	100,000 New	100,000 $2.22 Million

Others Institutions Holding CNTA

# of Institutions

Shares Held

84.5M

Call Options Held

17.7K

Put Options Held

View Full List

About Centessa Pharmaceuticals plc

Ticker CNTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,339,296
Market Cap $852M
Description
Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...

More about CNTA

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account